4.5 Review

Facioscapulohumeral Dystrophy

Journal

Publisher

SPRINGER
DOI: 10.1007/s11910-016-0667-0

Keywords

Muscular dystrophy; Genetics; Facioscapulohumeral dystrophy; DUX4; SCHMD1

Funding

  1. NIH
  2. FSH Society
  3. aTyr Pharma
  4. Acceleron

Ask authors/readers for more resources

Facioscapulohumeral muscular dystrophy (FSHD) is a clinically recognizable and relatively common muscular dystrophy. It is inherited mostly as an autosomal dominant disease or in a minority of cases, in a digenic pattern. The disease manifestation is variable and most likely dependent on genetic and epigenetic factors. We review the history, epidemiology, clinical presentation, and genetics of the disease, present the recently elucidated molecular pathogenesis, discuss the pathology and the possible consequence of the inflammation seen in the muscle biopsies, and consider future treatments.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available